Motivation: Assessing the therapeutic integration and contractile changes using matured pluripotent stem cell-derived cardiomyocytes (PSC-CMs) for myocardial infarction (MI) remains challenging. Current limitations in in vivo evaluation slow progress in developing PSC-CM therapy to attenuate remodeling after injury. Goal(s): To determine whether matured PSC-CMs improve ventricular function and scar integration using MRI biomarkers in a guinea pig model. Approach: Cine and diffusion MRI measured function and structure in cell-treated versus sham-treated animals, allowing in vivo assessment of regional and global function changes. Results: MRI revealed attenuated ventricular dilation and enhanced wall thickening in the scar region in treated animals, indicating functional integration of PSC-CMs. Impact: This study demonstrates that MRI biomarkers can assess PSC-CM therapy efficacy in vivo, providing a tool to refine regenerative treatments. By enabling precise monitoring of therapeutic integration, this approach may guide optimization of future regenerative therapies toward clinical applications.
No takes yet. Share an insight, caveat, or question.
Cook et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: